Professor, Brady Urological Institute

Director, Johns Hopkins Greenberg Bladder Cancer Institute

Johns Hopkins School of Medicine

Biography

David J. McConkey, Ph.D., is the inaugural director of the Johns Hopkins Greenberg Bladder Cancer Institute, Professor in the Department of Urology at Johns Hopkins Medicine, and The Erwin and Stephanie Greenberg Professor of Urology at the James Buchanan Brady Urological Institute. He received his undergraduate degree from Brown University and completed his doctoral thesis work at the Karolinska Institute, Stockholm, Sweden. He performed his postdoctoral research at the Dana-Farber Cancer Institute, Harvard Medical School before joining the faculty at University of Texas M.D. Anderson Cancer Center, where he served as Director of Urological Research from 2008-16. He was co-Principal Investigator of the M.D. Anderson Specialized Program of Research Excellence (SPORE) in Bladder Cancer and Chair for Translational Medicine for the Genitourinary Cancers Committee in the Southwest Oncology Group (SWOG). 

Research in Dr. McConkey’s laboratory is focused on using genomics to define the molecular mechanisms involved in bladder cancer progression and developing novel prognostic and predictive biomarkers. He has published more than 200 articles in peer reviewed journals and is on the editorial boards of Clinical Cancer Research, Molecular Cancer Therapeutics, and Bladder Cancer. He served on 90 advisory committees at M.D. Anderson and won numerous teaching awards for his work. In 2016, Dr. McConkey was awarded the JPB Foundation Bladder Cancer Research Innovation Award from the Bladder Cancer Advocacy Network (BCAN) where he also serves as a member of their Scientific Advisory Board.  Dr. McConkey is an active member of the American Association for Cancer Research (AACR), American Urological Association (AUA), the Society for Urologic Oncology (SUO), the American Society of Clinical Oncology, and the Society for Basic Urological Research (SBUR).